These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 30941136)

  • 21. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
    Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease.
    Kubiritova Z; Radvanszky J; Gardlik R
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
    Grabuschnig S; Bronkhorst AJ; Holdenrieder S; Rosales Rodriguez I; Schliep KP; Schwendenwein D; Ungerer V; Sensen CW
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
    Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
    EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives.
    Glebova KV; Veiko NN; Nikonov AA; Porokhovnik LN; Kostuyk SV
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):55-70. PubMed ID: 29303618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis.
    Viglianisi G; Santonocito S; Polizzi A; Troiano G; Amato M; Zhurakivska K; Pesce P; Isola G
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
    Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
    BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders.
    Drag MH; Kilpeläinen TO
    Physiol Genomics; 2021 Jan; 53(1):33-46. PubMed ID: 33346689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could high levels of cell-free DNA in maternal blood be associated with maternal health and perinatal outcomes?
    Konuralp Atakul B; Koc A; Adiyaman D; Kuyucu M; Sahingoz Yildirim AG; Saka Guvenc M; Erdogan KM; Sengul B; Oztekin DC
    J Obstet Gynaecol; 2020 Aug; 40(6):797-802. PubMed ID: 31769709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression.
    Alekseeva L; Mironova N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of circulating cell-free DNA and neutrophil proteins are associated with neonatal sepsis and necrotizing enterocolitis in immature mice, pigs and infants.
    Nguyen DN; Stensballe A; Lai JC; Jiang P; Brunse A; Li Y; Sun J; Mallard C; Skeath T; Embleton ND; Berrington JE; Sangild PT
    Innate Immun; 2017 Aug; 23(6):524-536. PubMed ID: 28714327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the Sclerostin
    Del Real A; Perez-Campo FM; Perez-Nuñez MI; Sañudo C; Santurtun A; Garcia-Ibarbia C; Garcia-Unzueta MT; Fraga MF; Fernandez AF; Valero MC; Laguna E; Riancho JA
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):42-47. PubMed ID: 33372860
    [No Abstract]   [Full Text] [Related]  

  • 33. The role and diagnostic value of cell-free DNA in systemic lupus erythematosus.
    Truszewska A; Foroncewicz B; Pączek L
    Clin Exp Rheumatol; 2017; 35(2):330-336. PubMed ID: 27908304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.
    Breitbach S; Tug S; Simon P
    Sports Med; 2012 Jul; 42(7):565-86. PubMed ID: 22694348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus.
    Zhang S; Lu X; Shu X; Tian X; Yang H; Yang W; Zhang Y; Wang G
    Intern Med; 2014; 53(24):2763-71. PubMed ID: 25500436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
    Sherwood K; Weimer ET
    J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties and Application of Cell-Free DNA as a Clinical Biomarker.
    de Miranda FS; Barauna VG; Dos Santos L; Costa G; Vassallo PF; Campos LCG
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-free DNA levels of twins and sibling pairs indicate individuality and possible use as a personalized biomarker.
    Alghofaili L; Almubarak H; Gassem K; Islam SS; Coskun S; Kaya N; Karakas B
    PLoS One; 2019; 14(10):e0223470. PubMed ID: 31600277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating, cell-free DNA as a marker for exercise load in intermittent sports.
    Haller N; Helmig S; Taenny P; Petry J; Schmidt S; Simon P
    PLoS One; 2018; 13(1):e0191915. PubMed ID: 29370268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases.
    Brezovec N; Perdan-Pirkmajer K; Čučnik S; Sodin-Šemrl S; Varga J; Lakota K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.